ALPN - Andrew S. Sandler is the new chief medical officer of Alpine Immune
Alpine Immune Sciences (NASDAQ:ALPN) appoints industry veteran Andrew S. Sandler, M.D., as its Chief Medical Officer effective August 17, 2022. Most recently Dr. Sandler was the Chief Medical Officer of Kiadis Pharma, a Sanofi Company. “I am thrilled to join the Alpine team and continue to advance the clinical strategy and development of the company’s extremely promising pipeline, including acazicolcept, davoceticept, and ALPN-303,” said Dr. Sandler
For further details see:
Andrew S. Sandler is the new chief medical officer of Alpine Immune